Markets & Regulations

Trump and COVID-19: treatments to date

05-Oct-2020 By Jenni Spinner

With the virus reaching the Oval Office, the presidential diagnosis is shining a spotlight on some of the drugs reportedly administered to the POTUS.

CPhI Festival of Pharma

CPhI Pharma Index survey reveals minds of CEOs

01-Oct-2020 By Jenni Spinner

The survey, unveiled ahead of next week's CPhI Festival of Pharma, reveals perspectives, concerns and future plans of more than 500 industry executives.

Deloitte survey reveals pharma CEO thoughts

21-Sep-2020 By Jenni Spinner

The latest iteration of the company’s Pharma CEO Survey offers information and insight as to how key industry figures are planning for the future.

Latest COVID-19 news from the FDA

17-Sep-2020 By Jenni Spinner

The US agency continues to issue advice for life-sciences professionals engaged in work related to the virus, and keep an eye out for fraudulent products.

CPhI Festival of Pharma

CPhI: cell and gene therapy capacity shortages on the horizon

16-Sep-2020 By Jenni Spinner

CPhI’s Annual Report 2020 predicts impending cell and gene capacity shortages for the US market, and possible mAb production growth in China.

CPhI Festival of Pharma

Women in pharma face unique obstacles: Shorla Pharma

16-Sep-2020 By Jenni Spinner

A cofounder of the Irish pharmaceutical firm will join others in sharing her perspective as a female pharmaceutical leader at this year’s CPhI event.

CPhI shifts from real-world to digital realm

16-Sep-2020 By Jenni Spinner

In the face of the COVID-19 pandemic, CPhI Festival of Pharma organizers have shifted the event online but kept the industry content.

Medable: COVID-19 fueling decentralized trial adoption

10-Sep-2020 By Jenni Spinner

The company credits its 400% year-over-year growth to rapid acceleration in adoption of virtual clinical trial technology, due in part to the vlrus.

Breaking FDA COVID-19 news

26-Aug-2020 By Jenni Spinner

The agency continues to take actions and issue advice related to COVID-19 treatments, tests, consumer products and other pressing industry concerns.

Thread Research lands $50m infusion for decentralized trial tech

25-Aug-2020 By Jenni Spinner

The clinical research tech provider has received a capital commitment from healthcare industry investors to advance its decentralized trial solutions.